TEDD Competence Centre - Tissue Engineering for Drug Development and Substance Testing
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement) in the long term.
Three-dimensional 3D cell models offer enormous innovation potentials for instance in medicine, to treat patients in a highly individualised way or in the food industry for the development of alternative methods to produce clean meat.
This year BIC offered a program with a special focus on microphysiological systems, de novo tissues and organoids.We hosted more than 200 international participants, speakers from academia and industry, and 22 exhibitors.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.